I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Stem Cells Research: A Sunrise Sector in Biotechnology Arena
Human Embryonic Stem Cells - An Introduction
Embryonic Stem Cells - Sources and Cell Culture
Comparison on Adult and Embryonic Stem Cells
Advantages and Drawbacks of Various Stem Cells
Recent Market Activity
Human Embryonic Stem Cells - The Market Perspective
Timeline for Embryonic Stem Cell Research Activities: Major
Events from 1963 through 2014
Teratomas - No Longer an Impediment to Stem Cell Therapy
Development
Human Embryonic and Induced Pluripotent Stem Cell Research Trends
Human Embryonic Stem Cell Research: Key Statistical Highlights
Research Topics on hESC and hiPSC by Number of Papers
Published: 2011-2013
Haploid Human Embryonic Stem Cell Line: The New Frontier
Human Induced Pluripotent Stem Cells Remains Best Alternative
for hESC
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
Astellas Institute of Regenerative Medicine (US)
Asterias Biotherapeutics, Inc. (US)
BD Biosciences (US)
Cell Cure Neurosciences Ltd. (Israel)
Cellular Dynamics International (US)
GE Healthcare (UK)
MilliporeSigma (US)
PerkinElmer, Inc. (US)
Reliance Life Sciences Ltd. (India)
Research & Diagnostics Systems, Inc. (US)
SABiosciences Corp. (US)
STEMCELL Technologies, Inc. (Canada)
Stemina Biomarker Discovery, Inc. (US)
Takara Bio, Inc. (Japan)
TATAA Biocenter AB (Sweden)
Thermo Fisher Scientific, Inc. (US)
UK Stem Cell Bank (UK)
ViaCyte, Inc. (US)
Vitrolife AB (Sweden)

3. MARKET TRENDS & DRIVERS
Issues Hindering Development of hESC Research
Consideration of Best Translational Pathways Pivotal in
Ensuring Growth Of hESCs
Ethical Issues and Technical Hurdles Bog Down hESC Research

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World 7-Year Perspective for Human Embryonic Stem Cell
(hESC) Research by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Regenerative
Medicine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 4: World 7-Year Perspective for Regenerative Medicine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 5: World Current & Future Analysis for Stem Cell Biology
Research by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 6: World 7-Year Perspective for Stem Cell Biology
Research by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 7: World Current & Future Analysis for Tissue Engineering
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World 7-Year Perspective for Tissue Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Toxicology Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 10: World 7-Year Perspective for Toxicology Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 11: USA Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Application - Regenerative
Medicine, Stem Cell Biology Research, Tissue Engineering and
Toxicology Testing - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 12: USA 7-Year Perspective for Human Embryonic Stem Cell
(hESC) Research by Application - Percentage Breakdown of Value
Sales for Regenerative Medicine, Stem Cell Biology Research,
Tissue Engineering and Toxicology Testing for the Years 2020 &
2027

CANADA
Table 13: Canada Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Application - Regenerative
Medicine, Stem Cell Biology Research, Tissue Engineering and
Toxicology Testing - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 14: Canada 7-Year Perspective for Human Embryonic Stem
Cell (hESC) Research by Application - Percentage Breakdown of
Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

JAPAN
Table 15: Japan Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Application - Regenerative
Medicine, Stem Cell Biology Research, Tissue Engineering and
Toxicology Testing - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 16: Japan 7-Year Perspective for Human Embryonic Stem
Cell (hESC) Research by Application - Percentage Breakdown of
Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

CHINA
Table 17: China Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Application - Regenerative
Medicine, Stem Cell Biology Research, Tissue Engineering and
Toxicology Testing - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 18: China 7-Year Perspective for Human Embryonic Stem
Cell (hESC) Research by Application - Percentage Breakdown of
Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

EUROPE
Table 19: Europe Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 20: Europe 7-Year Perspective for Human Embryonic Stem
Cell (hESC) Research by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK and
Rest of Europe Markets for Years 2020 & 2027

Table 21: Europe Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Application - Regenerative
Medicine, Stem Cell Biology Research, Tissue Engineering and
Toxicology Testing - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 22: Europe 7-Year Perspective for Human Embryonic Stem
Cell (hESC) Research by Application - Percentage Breakdown of
Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

FRANCE
Table 23: France Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Application - Regenerative
Medicine, Stem Cell Biology Research, Tissue Engineering and
Toxicology Testing - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 24: France 7-Year Perspective for Human Embryonic Stem
Cell (hESC) Research by Application - Percentage Breakdown of
Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

GERMANY
Table 25: Germany Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Application - Regenerative
Medicine, Stem Cell Biology Research, Tissue Engineering and
Toxicology Testing - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 26: Germany 7-Year Perspective for Human Embryonic Stem
Cell (hESC) Research by Application - Percentage Breakdown of
Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

ITALY
Table 27: Italy Current & Future Analysis for Human Embryonic
Stem Cell (hESC) Research by Application - Regenerative
Medicine, Stem Cell Biology Research, Tissue Engineering and
Toxicology Testing - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 28: Italy 7-Year Perspective for Human Embryonic Stem
Cell (hESC) Research by Application - Percentage Breakdown of
Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

UNITED KINGDOM
Table 29: UK Current & Future Analysis for Human Embryonic Stem
Cell (hESC) Research by Application - Regenerative Medicine,
Stem Cell Biology Research, Tissue Engineering and Toxicology
Testing - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 30: UK 7-Year Perspective for Human Embryonic Stem Cell
(hESC) Research by Application - Percentage Breakdown of Value
Sales for Regenerative Medicine, Stem Cell Biology Research,
Tissue Engineering and Toxicology Testing for the Years 2020 &
2027

REST OF EUROPE
Table 31: Rest of Europe Current & Future Analysis for Human
Embryonic Stem Cell (hESC) Research by Application -
Regenerative Medicine, Stem Cell Biology Research, Tissue
Engineering and Toxicology Testing - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 32: Rest of Europe 7-Year Perspective for Human Embryonic
Stem Cell (hESC) Research by Application - Percentage Breakdown
of Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

ASIA-PACIFIC
Table 33: Asia-Pacific Current & Future Analysis for Human
Embryonic Stem Cell (hESC) Research by Application -
Regenerative Medicine, Stem Cell Biology Research, Tissue
Engineering and Toxicology Testing - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 34: Asia-Pacific 7-Year Perspective for Human Embryonic
Stem Cell (hESC) Research by Application - Percentage Breakdown
of Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

REST OF WORLD
Table 35: Rest of World Current & Future Analysis for Human
Embryonic Stem Cell (hESC) Research by Application -
Regenerative Medicine, Stem Cell Biology Research, Tissue
Engineering and Toxicology Testing - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 36: Rest of World 7-Year Perspective for Human Embryonic
Stem Cell (hESC) Research by Application - Percentage Breakdown
of Value Sales for Regenerative Medicine, Stem Cell Biology
Research, Tissue Engineering and Toxicology Testing for the
Years 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 25